An AMS 1-2-3 IPO Guide: IPOs Have Windows?

In the world of Initial Public Offerings (IPOs), there are often well-recognized windows of opportunity. Typically, a down economy interrupts the flow of IPOs and diverts investment dollars into other vehicles, especially those seen as less risky. But today’s IPOs are more like going to the bank for a loan than the high-risk/high-potential reward investment they once were. Companies are more focused than ever on showing investors how they will protect their investment and allow them to get their money back. But there is still only a limited period of time where IPOs are feasible.

Read more: An AMS 1-2-3 IPO Guide: IPOs Have Windows?

Healthcare Reform & Profitability

Recently, Kevin Zerrenner, Director of Healthcare and Human Services at Accounting Management Solutions, contributed an article to Health Care Finance News, the leading publication for health care finance executives.

Kevin shares his unique wit and wisdom as his recent visit to the doctor’s office caused him to carefully consider the personal implications of healthcare reform. If you prefer getting stuck with a small needle to the BIG needle, be sure to read on…

Read more: Healthcare Reform & Profitability

Healthcare Rapid Diagnostic™

We understand that you, a healthcare provider, are feeling fiscal pressures from the economy, reductions in reimbursements and increased demand for services. And we know that now, more than ever, improving your financial operations efficiency and effectiveness is critical.

Qualifying Therapeutic Discovery Project Credit

On March 23, 2010, President Obama signed the Patient Protection and Affordable Care Act, H.R. 3590, into law.  The new law contains a potentially valuable new incentive for biotech companies: the Qualifying Therapeutic Discovery Project Credit, (Therapeutic Credit) enacted as Sec. 48D of the Internal Revenue Code.

Read more: Qualifying Therapeutic Discovery Project Credit